Bill Commons

NY A 2359

in committee

Relates to modifications and exceptions to case payment reimbursement rates for neoplastic disease care hospitals

New York · 2025-2026 Regular Session · lower

Quick answers

Did NY A 2359 pass?

Not yet. NY A 2359 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH

What is NY A 2359 about?

Provides per diem rates of payment by governmental agencies for inpatient services provided by facilities designated by the federal department of health and human services as exempt extended neoplastic disease care hospitals.

Who sponsors NY A 2359?

Amy Paulin is the primary sponsor of NY A 2359, joined by 1 cosponsor.

Description

Provides per diem rates of payment by governmental agencies for inpatient services provided by facilities designated by the federal department of health and human services as exempt extended neoplastic disease care hospitals.

Introduced
—
Latest action
2026-01-07 — REFERRED TO HEALTH
Bill type
bill
Last updated
—

Sponsors

  • Amy Paulinprimary
  • Michael Benedettocosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-01-16

    REFERRED TO HEALTH

    referral-committee

  2. 2026-01-07

    REFERRED TO HEALTH

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

  • Prior session: A 8883not in this corpus
  • Companion bill: S 3195

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 2359. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.